Eiko Lifesciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 7.87 | 11.01 | 8.50 |
| Operating Expense | 7.39 | 10.36 | 7.88 |
| Net Profit | 0.21 | 0.35 | 0.31 |
| Net Profit Margin | 2.67 | 3.18 | 3.65 |
| Earning Per Share | 0.16 | 0.27 | 0.28 |
| EBIDTA | 0.46 | 0.64 | 0.61 |
| Effective Tax Rate | 10.42 | 13.64 | 15.87 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 7.87 |
| Operating Expense | 7.39 |
| Net Profit | 0.21 |
| Net Profit Margin | 2.67 |
| Earning Per Share | 0.16 |
| EBIDTA | 0.46 |
| Effective Tax Rate | 10.42 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 27.93 | 18.32 | 25.41 |
| Operating Expenses Annual | 26.32 | 17.37 | 24.12 |
| Operating Profit Annual | 1.79 | 1.81 | 1.97 |
| Interest Annual | 0.14 | 0.15 | 0.46 |
| Depreciation | 0.66 | 0.63 | 0.56 |
| Net Profit Annual | 0.75 | 0.77 | 0.71 |
| Tax Annual | 0.23 | 0.26 | 0.24 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 27.93 |
| Operating Expenses Annual | 26.32 |
| Operating Profit Annual | 1.79 |
| Interest Annual | 0.14 |
| Depreciation | 0.66 |
| Net Profit Annual | 0.75 |
| Tax Annual | 0.23 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.61 | 0.22 | 4.07 |
| Cash Flow from Operations | -7.08 | 4.22 | -7.73 |
| Cash Flow from Investing | -0.55 | 0.87 | 0.59 |
| Cash Flow from Financing | 20.36 | -4.70 | 3.28 |
| Cash Flow at the End | 13.35 | 0.61 | 0.22 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.61 |
| Cash Flow from Operations | -7.08 |
| Cash Flow from Investing | -0.55 |
| Cash Flow from Financing | 20.36 |
| Cash Flow at the End | 13.35 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 6.44 | 9.93 | 7.79 |
| PBIT Margin (%) | 4.08 | 6.50 | 5.59 |
| PBT Margin (%) | -22.88 | -34.11 | -6.14 |
| Net PROFIT Margin (%) | 2.69 | 4.20 | 2.79 |
| Return On Networth / Equity (%) | 1.87 | 2.65 | 3.45 |
| Return On Networth /Employed (%) | 2.82 | 3.79 | 6.01 |
| Return On Assets (%) | 1.88 | 2.44 | 2.99 |
| Total Debt / Equity (X) | TBA | 0.08 | 0.16 |
| Asset Turnover Ratio (%) | 0.70 | 0.58 | 1.07 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 6.44 |
| PBIT Margin (%) | 4.08 |
| PBT Margin (%) | -22.88 |
| Net PROFIT Margin (%) | 2.69 |
| Return On Networth / Equity (%) | 1.87 |
| Return On Networth /Employed (%) | 2.82 |
| Return On Assets (%) | 1.88 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.70 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 13.57 | 13.88 | 14.29 |
| Total Current Assets Annual | 30.93 | 9.30 | 12.44 |
| Non Current Assets Annual | 21.81 | 21.74 | 22.46 |
| Total Shareholders Funds Annual | 50.68 | 29.42 | 28.63 |
| Total Assets Annual | 52.74 | 31.04 | 34.89 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 13.57 |
| Total Current Assets Annual | 30.93 |
| Non Current Assets Annual | 21.81 |
| Total Shareholders Funds Annual | 50.68 |
| Total Assets Annual | 52.74 |
EPS (INR)
Expected
0.22
Reported
0.22
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Sep 2020
EPS beaten by 0.00%
Jun 2020
EPS beaten by 0.00%
